Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn whether higher doses of stem cells can
help to decrease the symptoms that occur after melphalan. Another goal of the study is to see
how the dose of infused stem cells affects the levels of certain proteins in your blood.
Researchers also want to learn how the dose of stem cells that you receive affects the
quality of your life during the weeks after the transplant procedure.